Perspectives for the Treatment of Infections with Flaviviridae
- 1 January 2000
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 13 (1), 67-82
- https://doi.org/10.1128/cmr.13.1.67-82.2000
Abstract
The ASM Review journal Clinical Microbiology Reviews analyzes the latest developments in clinical microbiology and immunology. Read and join our community.Keywords
This publication has 88 references indexed in Scilit:
- Genetic variability of classical swine fever virusVirus Research, 1996
- A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 proteaseJournal of General Virology, 1996
- Enzymatic characterization of purified NS3 serine proteinase of hepatitis C virus expressed inEscherichia coliFEBS Letters, 1996
- Neuraminidase Augments Fc Receptor II-Mediated Antibody-Dependent Enhancement of Dengue Virus InfectionJournal of General Virology, 1993
- An efficient method for production of purified inactivated Japanese encephalitis vaccine from mouse brainsVaccine, 1991
- Differences in fusogenicity and mouse neurovirulence of Japanese encephalitis virusesArchiv für die gesamte Virusforschung, 1991
- Treatment of chronic hepatitis C with recombinant α-interferon. A multicentre randomized, controlled trialJournal of Hepatology, 1990
- FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATIONAnnual Review of Microbiology, 1990
- Lassa FeverNew England Journal of Medicine, 1986
- The broad spectrum antiviral agent ribavirin inhibits capping of mRNABiochemical and Biophysical Research Communications, 1979